Using a lower dose of melanoma immunotherapy may extend survival while reducing dangerous side effects. New research suggests that reducing the dose of a commonly used immunotherapy for malignant melanoma may actually improve treatment results while lowering the risk of side effects. Scientists at Karolinska Institutet reported the findings in the Journal of the National […]Health,Cancer,Immunotherapy,Karolinska Institutet,Melanoma,Oncology,Skin Cancer#Dose #Skin #Cancer #Treatment #Delivers #Shockingly #Results1771562821
